| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
APPETITE, OBESITY, DIGESTION, AND METABOLISM
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
Submitted 6 August 2004 ; accepted in final form 20 September 2004
Peptide YY3–36 [PYY(3–36)], a gastrointestinal peptide that is released into the circulation in response to ingesting a meal, has recently been suggested to play a role in controlling food intake. PYY(3–36) has been reported to inhibit food intake following peripheral administration in rodents and in human subjects. To more fully characterize the potential feeding actions of PYY(3–36), we examined the ability of a dose range of PYY(3–36) (0.3–3.0 nmol/kg) to affect liquid gastric emptying and daily 6-h food intake in male rhesus monkeys. Intramuscular PYY(3–36) produced a dose-related inhibition of saline gastric emptying that was maximal at a dose of 3 nmol/kg. Intramuscular PYY(3–36) administered before daily 6-h food access produced significant feeding reductions at doses of 1 and 3 nmol/kg. Analyses of the patterns of food intake across the 6-h period of food access revealed that PYY(3–36) increased the latency to the first meal and reduced average meal size without altering meal number. Although single doses of PYY(3–36) reduced intake, a suppressive effect on food intake was not sustained over multiple administrations across successive days. Together, these data suggest that PYY(3–36) has the ability to reduce food intake in acute test situations in nonhuman primates. Whether this is a physiological action of the endogenous peptide remains to be determined.
satiety; meal patterns; gut peptides
This article has been cited by other articles:
|
|
 |
|
  D. D'Alessio Intestinal Hormones and Regulation of Satiety: The Case for CCK, GLP-1, PYY, and Apo A-IV JPEN J Parenter Enteral Nutr, September 1, 2008; 32(5): 567 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Unniappan and T. J. Kieffer Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R51 - R58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. C. Parkinson, W. S. Dhillo, C. J. Small, O. B. Chaudhri, G. A. Bewick, I. Pritchard, S. Moore, M. A. Ghatei, and S. R. Bloom PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E698 - E708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. E. Ghitza, S. G. Nair, S. A. Golden, S. M. Gray, J. L. Uejima, J. M. Bossert, and Y. Shaham Peptide YY3-36 Decreases Reinstatement of High-Fat Food Seeking during Dieting in a Rat Relapse Model J. Neurosci., October 24, 2007; 27(43): 11522 - 11532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Scott and T. H. Moran The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R983 - R987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R39 - R46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Ladenheim Peptide YY(3-36) and food intake: a peptide waiting for a paradigm? Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R37 - R38. [Full Text] [PDF]
|
|
|
|
|
|
N. Vrang, A. N. Madsen, M. Tang-Christensen, G. Hansen, and P. J. Larsen PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R367 - R375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Chaudhri, C. Small, and S. Bloom Gastrointestinal hormones regulating appetite Phil Trans R Soc B, July 29, 2006; 361(1471): 1187 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Chelikani, A. C. Haver, J. R. Reeve Jr., D. A. Keire, and R. D. Reidelberger Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R298 - R305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Adams, C. Lei, C. M. Jodka, S. E. Nikoulina, J. A. Hoyt, B. Gedulin, C. M. Mack, and E. S. Kendall PYY[3-36] Administration Decreases the Respiratory Quotient and Reduces Adiposity in Diet-Induced Obese Mice J. Nutr., January 1, 2006; 136(1): 195 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Cupples Physiological regulation of food intake Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1438 - R1443. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schonhoff, L. Baggio, C. Ratineau, S. K. Ray, J. Lindner, M. A. Magnuson, D. J. Drucker, and A. B. Leiter Energy Homeostasis and Gastrointestinal Endocrine Differentiation Do Not Require the Anorectic Hormone Peptide YY Mol. Cell. Biol., May 15, 2005; 25(10): 4189 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Badman and J. S. Flier The Gut and Energy Balance: Visceral Allies in the Obesity Wars Science, March 25, 2005; 307(5717): 1909 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Benoit and M. H. Tschop PYY3-36 "monkeys around" with energy balance Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R358 - R359. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
